Search

3 result(s) for 'author#John A M Ramshaw' within BMC

1. Towards scalable production of a collagen-like protein from Streptococcus pyogenes for biomedical applications

   Collagen has proved valuable as biomedical materials for a range of clinical applications, particularly in wound healing. It is normally produced from animal sources, such as from bovines, but concerns have em...

   Authors: Yong Y Peng, Linda Howell, Violet Stoichevska, Jerome A Werkmeister, Geoff J Dumsday and John A M Ramshaw

   Citation: Microbial Cell Factories 2012 11:146

   Content type: Research Published on: 5 November 2012

   • View Full Text
   • View PDF

2. Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis

   Antibodies against intact type II collagen (CII) are a feature of rheumatoid arthritis (RA) but have limited diagnostic value. Here we assess whether either of the two major cyanogen bromide fragments of CII, ...

   Authors: Andrew D Cook, Robyn Gray, John Ramshaw, Ian R Mackay and Merrill J Rowley

   Citation: Arthritis Res Ther 2004 6:R477

   Content type: Research article Published on: 11 August 2004

   • View Full Text
   • View PDF

3. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

   For adults surviving stroke due to spontaneous (non-traumatic) intracerebral haemorrhage (ICH) who had taken an antithrombotic (i.e. anticoagulant or antiplatelet) drug for the prevention of vaso-occlusive dis...

   Authors: Rustam Al-Shahi Salman, Martin S. Dennis, Gordon D. Murray, Karen Innes, Jonathan Drever, Lynn Dinsmore, Carol Williams, Philip M. White, William N. Whiteley, Peter A. G. Sandercock, Cathie L. M. Sudlow, David E. Newby, Nikola Sprigg and David J. Werring

   Citation: Trials 2018 19:162

   Content type: Study protocol Published on: 5 March 2018

   • View Full Text
   • View PDF